Oct 08, 2025
Penumbra, Inc. Schedules Investor Event at TCT Conference on October 26, 2025; Earnings Release and Conference Call for Third Quarter 2025 Scheduled for November 5, 2025
Aug 27, 2025
Penumbra, Inc. Names Shruthi Narayan as Company President
Aug 20, 2025
Penumbra, Inc. to Present at Upcoming Investor Conferences
Jul 30, 2025
Penumbra, Inc. to Present at the Canaccord Genuity 45th Annual Growth Conference
Jul 29, 2025
Penumbra, Inc. Reports Second Quarter 2025 Financial Results
Jun 05, 2025
Penumbra Introduces the Ruby® XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization
Apr 29, 2025
Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference
Apr 03, 2025
Penumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025
Apr 02, 2025
Seven New Data Sets Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits
Feb 21, 2025
Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors
Feb 18, 2025
Penumbra, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
Jan 21, 2025
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025
Nov 20, 2024
Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference
Nov 05, 2024
New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options
Oct 30, 2024
Penumbra, Inc. Reports Third Quarter 2024 Financial Results
Oct 02, 2024
Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024
Sep 16, 2024
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash(TM) 2.0 and Lightning Bolt(TM) 7 - in Europe
Aug 27, 2024
Penumbra, Inc. to Present at the Baird Global Healthcare Conference
Aug 21, 2024
Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference
Aug 13, 2024
Penumbra, Inc. Announces $200 Million Share Repurchase Authorization